PMC:7652766 / 98203-98544
Annnotations
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T479 | 0-341 | Sentence | denotes | Hung et al. (322) assessed the effect of IFN-β on COVID-19 patients and found that the triple combination of IFN-β1b, lopinavir/ritonavir, and ribavirin was safer and more effective than lopinavir/ritonavir alone at alleviating symptoms, shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3617 | 41-46 | Gene | denotes | IFN-β | Gene:3439 |
| 3618 | 59-67 | Species | denotes | patients | Tax:9606 |
| 3619 | 301-309 | Species | denotes | patients | Tax:9606 |
| 3626 | 118-137 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 3627 | 143-152 | Chemical | denotes | ribavirin | MESH:D012254 |
| 3628 | 187-206 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 3632 | 50-58 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 3633 | 332-340 | Disease | denotes | COVID-19 | MESH:C000657245 |